IPO
BioXcel Therapeutics, Inc.
They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.
Symbol
BTAI
Price Range
$11.00 - $13.00
Effective Date
March 8, 2018
Underwriters
Barclays, UBS Investment Bank, BMO Capital Markets
To view the prospectus for BioXcel Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277